DGX
Quest Diagnostics IncorporatedNYSEHealthcare$198.02+0.17%ClosedMarket Cap: $22.03B
As of 2026-04-06
Insider Statistics (Q2 2026)
Purchases
1
Sales
0
Buy/Sell Ratio
0.00
Total Bought
$0.00
Total Sold
$0.00
Recent Insider Trades
| Filing Date | Name | Type | Action | Shares | Price | Shares After |
|---|---|---|---|---|---|---|
| Thu Apr 02 | WENTWORTH TIMOTHY C | director | Sell | 198 | $0.00 | 198 |
| Wed Mar 11 | WENTWORTH TIMOTHY C | director: | Sell | 0 | $0.00 | 0 |
| Wed Mar 11 | WENTWORTH TIMOTHY C | director | Sell | 215 | $0.00 | 215 |
| Fri Mar 06 | SAMAD SAM | officer: Executive Vice President & CFO | Sell | 7,720 | $204.86 | 33,268 |
| Fri Mar 06 | Doherty Catherine T. | officer: EVP, Regional Businesses | Sell | 11,364 | $204.86 | 78,486 |
| Fri Mar 06 | Doherty Catherine T. | officer: EVP, Regional Businesses | Sell | 5,806 | $204.86 | 72,680 |
| Fri Mar 06 | Doherty Catherine T. | officer: EVP, Regional Businesses | Sell | 5,558 | $206.21 | 67,122 |
| Fri Mar 06 | DELANEY MARK E | officer: SVP & Chief Commercial Officer | Sell | 5,682 | $204.86 | 14,190 |
| Fri Mar 06 | DELANEY MARK E | officer: SVP & Chief Commercial Officer | Sell | 2,326 | $204.86 | 11,864 |
| Fri Mar 06 | PREVOZNIK MICHAEL E | officer: SVP & General Counsel | Sell | 7,232 | $204.86 | 44,789 |
| Fri Mar 06 | SAMAD SAM | officer: Executive Vice President & CFO | Sell | 13,947 | $204.86 | 40,988 |